NexPoint Life Sciences II DST

Amendment
CIK: 0001980223·Other Real Estate·DELAWARE·Filed: Dec 13, 2023
Total Offering

$40,489,695

Amount Sold

$11,282,417

Investors

37

First Sale

Jun 20, 2023

Offering Details

Type
Equity
Exemptions
Rule 506(c), Section 3(c), Section 3(c)(5)
Entity Type
Other
Year Incorporated
2023
Non-Accredited Investors
No

Related Persons

NameRole
NexPoint Real Estate Advisors IV, L.P.
Related Person
Matthew Goetz
Related Person
NREA Life Sciences II, LLC
Related Person
NREA LS II Investment Co, LLC
Related Person
Matt McGraner
Related Person

Company

NexPoint Life Sciences II DST

300 CRESCENT COURT

DALLAS, TX, 75201

833-697-6246

SEC Filing

0001980223-23-000010

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free